Radiation recall reaction with docetaxel administration after accelerated partial breast irradiation with electronic brachytherapy

Brachytherapy

Volumn 8, Issue 3, 2009, Pages 331-334

  Chen, Sea S ^a   Strauss, Jonathan B ^a   Shah, Anand P ^a   Rao, Ruta D ^a   Bernard, Damien A ^a   Griem, Katherine L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Docetaxel; Electronic brachytherapy; Partial breast irradiation; Radiation recall reaction

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; IRIDIUM 192; TAMOXIFEN CITRATE;

ADULT; ARTICLE; BRACHYTHERAPY; BREAST BIOPSY; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; ELECTRONIC BRACHYTHERAPY; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MULTIPLE CYCLE TREATMENT; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION RECALL REACTION; SKIN MANIFESTATION; SKIN ULCER; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RADIODERMATITIS; TAXOIDS;

EID: 67651020811     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2009.01.001     Document Type: Article

References (12)

1. Vicini F.A., Beitsch P., Quiet C., et al. Three-year analysis of treatment efficacy, cosmesis and toxicity by the American Society of Breast Surgeons (ASBS) MammoSite breast brachytherapy registry trial in patients treated with accelerated partial breast irradiation (APBI). Cancer 112 (2008) 758-766
2. Chao K.K., Vicini F.A., Wallace M., et al. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: The William Beaumont Hospital experience. Int J Radiat Oncol Biol Phys 69 (2007) 32-40
3. Dragun A.E., Harper J.L., Jenrette J.M., et al. Predictors of cosmetic outcome following MammoSite breast brachytherapy: A single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys 68 (2007) 354-358
4. Camidge R., and Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 59 3 (2001) 237-245
5. Borgia F., Guarneri C., Guarneri F., et al. Radiation recall dermatitis after docetaxel administration: Absolute indication to replace the drug?. Br J Dermatol 153 (2005) 674-675
6. Recht A., Come S.E., Henderson I.C., et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 334 (1996) 1356-1361
7. Benitez P.R., Keisch M.E., Vicini F., et al. Five-year results: The initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 194 (2007) 456-462
8. Vicini F.A., Beitsch P.D., Quiet C.A., et al. First analysis of patient demographics, technical reproducibililty, cosmesis, and early toxicity: Results of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Cancer 104 (2005) 1138-1148
9. Haffty B.G., Vicini F.A., Beitsch P., et al. Timing of chemotherapy after MammoSite radiation therapy system breast brachytherapy: Analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Int J Radiat Oncol Biol Phys 72 (2008) 1441-1448
10. Dickler A., Kirk M.C., Seif N., et al. A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy. Brachytherapy 6 (2007) 164-168
11. Niehoff P., Ballardini B., Polgár C., et al. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer. Breast 15 (2006) 319-325
12. Brenner D.J., Leu C.-S., Beatty J.F., et al. Clinical relative biological effectiveness of low-energy x-rays emitted by miniature x-ray devices. Phys Med Biol 44 (1999) 323-333